Synlogic Stock Price

0.30 (9.49%)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Synlogic Inc SYBX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.30 9.49% 3.46 17:59:00
Open Price Low Price High Price Close Price Prev Close
3.25 3.24 3.62 3.46 3.16
Bid Price Ask Price Spread News
3.29 3.59 0.30 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,046 433,178 $ 3.47 $ 1,502,022 343,463 1.68 - 5.11
Last Trade Time Type Quantity Stock Price Currency
16:42:08 7 $ 3.46 USD

Synlogic Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 175.18M 50.63M 35.36M $ 545.00k $ - -1.64 -2.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 3.86M 2.80%

more financials information »

Synlogic News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SYBX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.133.802.913.331,961,0560.3310.54%
1 Month3.003.872.913.35768,5590.4615.33%
3 Months4.535.102.913.57539,032-1.07-23.62%
6 Months2.145.112.01993.011,230,9481.3261.68%
1 Year2.135.111.682.87720,3191.3362.44%
3 Years11.8414.591.353.57387,997-8.38-70.78%
5 Years10.3023.001.353.90329,652-6.84-66.41%

Synlogic Description

Synlogic Inc is a biopharmaceutical company focused on the discovery and development of Synthetic Biotic medicines which are designed to metabolize a toxic substance, compensate for missing or damaged metabolic pathways, or deliver combinations of therapeutic factors. Synthetic Biotic medicines are generated from the company's proprietary drug discovery and development platform, using Synthetic Biology and leveraging a reproducible, modular approach to develop beneficial microbes that perform or deliver critical therapeutic functions. Its key product candidate is SYNB1618, an oral therapy intended for the treatment of PKU, a rare metabolic disease in which an amino acid known as phenylalanine accumulates in the body as a result of genetic defects.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210514 23:03:50